Showing results (511-520 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 2, 2021
Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis - A cohort studyHilde Marie Torgauten, Kjell-Morten Myhr, Stig Wergeland, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 31, 2020
Breastfeeding is associated with reduced risk of multiple sclerosis in males, predominantly among HLA-DRB1*15:01 carriersA K Hedström, C Adams, X Shao, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 4, 2023
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trialGary Cutter, Richard A Rudick, Carl de Moor, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 27, 2023
Severity and worsening of fatigue among individuals with multiple sclerosisAmber Salter, Alexander Keenan, Hoa H Le, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 23, 2021
Virtual reality is a feasible intervention platform in multiple sclerosis: A pilot protocol and acute improvements in affectMichael T Shaw, Maria J Palmeri, Martin Malik, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progressionMarco Tk Law, Anthony L Traboulsee, David Kb Li, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 5, 2020
White matter lesion location correlates with disability in relapsing multiple sclerosisLaura Gaetano, Baldur Magnusson, Petya Kindalova, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 6, 2020
HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohortMaria Gontika, Charalampos Skarlis, Artemios Artemiadis, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 5, 2019
ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factorItziar Lopetegi, Amaia Muñoz-Lopetegi, Maialen Arruti, et al.
Pageof 61